Platform
The Unlearn Platform
Digital Twin Generators
Research
Artificial Intelligence
Clinical Research
Company
Evidence
About
Careers
Blog
Press
Evidence
Blog
Our Perspectives
Latest
How Unlearn Boosts Trial Power Using the FDA’s AI Framework
Filter and sort
Topics
Tag 1
machine-learning, digital-twins, digital-twin-generators, regulatory, twinrcts, unlearn-ing
Disease
Tag 1
alzheimers-disease, amyotrophic-lateral-sclerosis, asthma, atopic-dermatitis, copd, coronary-artery-disease, crohns-disease, dyslipidemia, frontotemporal-dementia, huntingtons-disease, hypertension, migraine, obesity, osteoarthritis, osteoporosis, parkinsons-disease, psoriasis, psoriatic-arthritis, rheumatoid-arthritis, sci, stroke, type-2-diabetes, ulcerative-colitis
Date
Tag 1
2024, 2023, 2022
Text Link
2022
Text Link
2023
Text Link
2024
Text Link
2025
Text Link
Alzheimer’s disease
Text Link
Amyotrophic Lateral Sclerosis
Text Link
Atopic Dermatitis
Text Link
Crohn’s disease
Text Link
Dyslipidemia
Text Link
Frontotemporal dementia
Text Link
Huntington's disease
Text Link
Hypertension
Text Link
Parkinson's disease
Text Link
Psoriasis
Text Link
Rheumatoid Arthritis
Text Link
Stroke
Text Link
Type 2 Diabetes
Text Link
Data
Text Link
Digital Twin Generators
Text Link
Digital Twins
Text Link
Machine Learning
Text Link
Regulatory
Text Link
TwinRCTs
Text Link
Unlearn-ing
Sort by
Date (Newest)
Date (Oldest)
Name (A to Z)
Name (Z to A)
Sort By
Name (A-Z)
Name (Z-A)
Date (newest)
Date (oldest)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
amyotrophic-lateral-sclerosis, 2025, digital-twins
How we’re helping biotechs like ProJenX run smarter ALS trials
2025, digital-twins, parkinsons-disease
Unlocking Smarter Parkinson’s Disease Trials with Digital Twins
2025, alzheimers-disease, amyotrophic-lateral-sclerosis, huntingtons-disease, parkinsons-disease, digital-twin-generators
Smarter Endpoints, Stronger Trials: How AI-Optimized Measures Are Advancing Neurodegenerative Disease Research
unlearn-ing
Why the FDA’s New AI Guidelines Matter for Clinical Research
2024, data, amyotrophic-lateral-sclerosis
Why Unlearn and APST’s Partnership Matters for ALS Innovation
Supporting Every Stakeholder in Clinical Trials with AI-Powered Digital Twins
Unlearn’s Next Chapter: Scaling AI in Healthcare
New Model Release for ALS: Accelerating Clinical Trials with Advanced Forecasting
Unlearn Introduces Digital Twin Generators for Psychiatric Disorders
1 / 6
Next
Text Link
2022
Text Link
2023
Text Link
2024
Text Link
2025
Text Link
Alzheimer’s disease
Text Link
Amyotrophic Lateral Sclerosis
Text Link
Atopic Dermatitis
Text Link
Crohn’s disease
Text Link
Dyslipidemia
Text Link
Frontotemporal dementia
Text Link
Huntington's disease
Text Link
Hypertension
Text Link
Parkinson's disease
Text Link
Psoriasis
Text Link
Rheumatoid Arthritis
Text Link
Stroke
Text Link
Type 2 Diabetes
Text Link
Data
Text Link
Digital Twin Generators
Text Link
Digital Twins
Text Link
Machine Learning
Text Link
Regulatory
Text Link
TwinRCTs
Text Link
Unlearn-ing
Text Link
Date: 2022
Text Link
Date: 2023
Text Link
Date: 2024
Text Link
Date: 2025
Text Link
Diseases: Alzheimer’s disease
Text Link
Diseases: Amyotrophic Lateral Sclerosis
Text Link
Diseases: Atopic Dermatitis
Text Link
Diseases: Crohn’s disease
Text Link
Diseases: Dyslipidemia
Text Link
Diseases: Frontotemporal dementia
Text Link
Diseases: Huntington's disease
Text Link
Diseases: Hypertension
Text Link
Diseases: Parkinson's disease
Text Link
Diseases: Psoriasis
Text Link
Diseases: Rheumatoid Arthritis
Text Link
Diseases: Stroke
Text Link
Diseases: Type 2 Diabetes
Text Link
Topics: Data
Text Link
Topics: Digital Twin Generators
Text Link
Topics: Digital Twins
Text Link
Topics: Machine Learning
Text Link
Topics: Regulatory
Text Link
Topics: TwinRCTs
Text Link
Topics: Unlearn-ing
Virtual Event
The next generation of AI powered clinical trials
Tuesday, June 27 2:30pm PDT
Register
